Apidra is a registered trademark of Sanofi-Aventis U.S. LLC [1].
Who Else Makes Apidra?
Sanofi is the current owner of the Apidra trademark. However, patent expirations can lead to other companies manufacturing and marketing generic versions of the drug. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can indicate when generic competition might emerge [2].
When Does Apidra's Patent Expire?
Information regarding specific patent expiry dates for Apidra is available through patent tracking resources. These resources often detail the patents protecting a drug and their projected expiration [2].
What is Apidra Used For?
Apidra is a rapid-acting insulin used to control high blood sugar in adults and children who have diabetes [3]. It is a mealtime insulin that begins to work quickly and can be taken shortly before meals or after starting to eat [3].
How Does Apidra Work?
Apidra is a human insulin analog that works by lowering blood glucose. It is absorbed faster and has a shorter duration of action than regular human insulin, making it suitable for prandial (mealtime) insulin therapy [4].
What Are the Risks or Side Effects of Apidra?
Common side effects of Apidra include low blood sugar (hypoglycemia), allergic reactions, injection site reactions, and changes in body fat at injection sites. Serious side effects can include severe allergic reactions, swelling, and weight gain. Hypoglycemia is the most common and potentially serious side effect [3].
What Are Other Insulin Options?
Besides Apidra, other rapid-acting insulins include Humalog (insulin lispro) and Novolog (insulin aspart). Sanofi also produces Lantus (insulin glargine), a long-acting insulin, and Toujeo (insulin glargine), another long-acting insulin [5].
What is the Difference Between Apidra and Other Insulins?
Apidra is a rapid-acting insulin, meaning it starts working quickly after injection and is typically used to cover meals. Other types of insulin include short-acting (regular) insulin, intermediate-acting insulin (like NPH), and long-acting insulins, which provide basal (background) coverage. The choice of insulin depends on an individual's diabetes management needs [4, 5].
How Much Does Apidra Cost?
The cost of Apidra can vary depending on insurance coverage, pharmacy, and dosage. Without insurance, the retail price can be substantial. Patient assistance programs and coupons may be available to help reduce the cost [6].
Sources:
[1] https://www.drugpatentwatch.com/sanofi
[2] https://www.drugpatentwatch.com/
[3] https://www.apidra.com/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769246/
[5] https://www.drugpatentwatch.com/sanofi/lantus
[6] https://www.goodrx.com/apidra